Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:31 AM
Ignite Modification Date:
2025-12-25 @ 2:31 AM
NCT ID:
NCT00078234
Eligibility Criteria:
Key Inclusion Criteria:
* Absolute lymphocyte count of \> 10,000 cells/mm3 or history of ALC \>10,000 cell/mm3
* Platelets \> 50,000 cells/mm3
* Tumor lymphocytes expressing surface CD5, CD19, CD20 and CD23
* Creatinine \< 1.5 mg.dL
Key Exclusion Criteria:
* Less than 3 weeks from any prior major surgery or other therapy for CLL including radiation therapy, chemotherapy, high-dose steroid therapy, immunotherapy, cytokine, biologic or vaccine therapy.
* History of autoimmune hemolytic anemia
* Prior allogeneic transplant
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00078234
Study Brief:
Protocol Section:
NCT00078234